Janelle Hart

"Although, as urologic oncologists, we all see a few cases in our practices individually, I think, no question, there's a lot of heterogeneity in how penile cancer is managed across the United States," says Philippe E. Spiess, MD, MS.

In a recent interview, Mark A. Moyad, MD, MPH, discusses his personal experience with identity theft and why health care professionals should pay more attention to this topic.

In a recent interview, recipient of the Society of Women in Urology’s 2021 Outstanding Resident Award, Efe Chantal Ghanney Simons, MD, discusses the improvements that are needed for women in urology

In a recent interview, Neil H. Bander, MD, emphasizes some of the specific innovations that are on the horizon for PSMA.

"Telemedicine is a really useful adjunct to people's practices," says Kara L. Watts, MD.

"This is a way for us to get high doses of radiation to sites of tumors," says Michael S. Hofman, MBBS (Hons), FAANMS, FICIS.

"I don't think we're doing enough. Absolutely not. Otherwise, we'd be in a different situation," says Diana Londoño, MD.

"Essentially, we were interested in learning whether there was a change in the amount of curvature with each injection cycle of Xiaflex," says Matthew J. Ziegelmann, MD.

"This is still really a male-dominated field; however, the patient population is well mixed. There's men and women that are patients, and a lot of female patients are requesting female urologists," said Jennifer Miles-Thomas, MD.

“Yoga improved quality of life in men compared to the standard of care, specifically on the fatigue scale, meaning they were less tired; on sexual function; and on their functional, physical and social wellbeing,” said Dharam Kaushik, MD.

In 2 recent studies led by Naeem Bhojani, MD, FRCSC, and Ben H. Chew, MD, MSc, investigators performed a meta-analysis to identify predictors of sepsis as well as the cost of sepsis for patients with stone disease.

“The initial phase 1b data of batiraxcept in combination with cabozantinib are impressive and point toward the role of dual AXL and VEGF inhibition in the treatment of clear cell renal cell carcinoma,” said Eric Jonasch, MD.

In this interview, Jason M. Hafron, MD, discusses the “buzz” surrounding the meeting and touches on clinical topics including germline and somatic testing, PARP inhibitors, and mitomycin-containing reverse thermal gel (Jelmyto).

"The key to active surveillance is an acceptance between the patient's family, the patient, and the physician to monitor this cancer," says Behfar Ehdaie, MD, MPH.

"At the end of the day, the idea is that it shows you what your next steps are based on what the AUA and SUO guidelines are for non–muscle invasive bladder cancer," says Chad R. Ritch, MD, MBA, FACS.

"These findings underscore the importance of screening guidelines from the task force and the rapid responsiveness of clinicians and patients,” said Michael S. Leapman, MD.

Steven A. Kaplan, MD, highlights the latest developments in BPH and previews what's on the horizon in the space.

"Of note, there have been no studies demonstrating that vaccines negatively impact fertility or cause sterility in either sex," said Ranjith Ramasamy, MD.

In a recent study presented at the 2021 SMSNA Fall Scientific Meeting, Kevin J. Campbell, MD, MS, and a team of investigators examined the correlations between finasteride and drugs used to treat hypogonadism and sexual dysfunction in order to understand how best to prescribe this medication in terms of lowering adverse drug reactions.

Jesse N. Mills, MD, also highlights a few other key studies that were also presented at the 2021 Sexual Medicine Society of North America Fall Scientific Meeting

In a recent study presented at the 2021 SMSNA Fall Scientific Meeting, Jay Newmark, MD, MBA, and co-authors report promising findings on the first experiences of patients using JATENZO in the real world.

In a recent study published in Urology, a team of investigators compared opioid prescribing patterns among urologists around the world.

In this interview, Michael Schweizer, MD, highlights a study of olaparib plus bipolar androgen therapy in patients with metastatic castration-resistant prostate cancer.

The FDA previously approved the Ieva Digital Therapeutic System for the treatment of urinary incontinence and pelvic floor strengthening in women.

The study is specifically exploring the combination in patients with MET-driven kidney cancer.

In a recent study Martin M. Miner, MD, and co-authors investigated the effect of BMI on the pharmacokinetic profile or dosing of testosterone therapies in men with TD.

"We should think about a man’s mentality and recognize the impact on his overall physical, mental, emotional health. Sexual function is part of all that wellness, so I would certainly underscore that message we're talking about today," said Arthur L. Burnett, MD, MBA, FACS.

A recent study sought to investigate the trends in sudden and significant private equity acquisitions among urology practices between 2011 and 2021.

By the end of a 12-week period, total testosterone C-trough, C-avg (0 to 168 hours), and C-max were inversely related to BMI.

Although there was no significant change in the erect or the stretched penile length in patients who responded to the injections, results showed that there was a significant decrease in the erect circumference among the majority of patients.